title: Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection.
authors.forename: Lorenzo A
authors.initials: LA
authors.lastname: Calò
authors.forename: Elisa
authors.initials: E
authors.lastname: Pagnin
authors.forename: Michelangelo
authors.initials: M
authors.lastname: Sartori
authors.forename: Andrea
authors.initials: A
authors.lastname: Semplicini
authors.forename: Achille C
authors.initials: AC
authors.lastname: Pessina
mesh_terms: D001477:Bartter Syndrome / Q000188:drug therapy* / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000378:metabolism / Q000517:prevention & control*; D007008:Hypokalemia / Q000188:drug therapy* / Q000378:metabolism; D047908:Intracellular Signaling Peptides and Proteins; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D054460:rho-Associated Kinases
chemical_list: D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases